Clinical Trial Detail

NCT ID NCT03425279
Title CAB-AXL-ADC Safety and Efficacy Study in Patients With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioAtla, LLC
Indications

melanoma

lung non-small cell carcinoma

Advanced Solid Tumor

pancreatic ductal adenocarcinoma

Therapies

CAB-AXL-ADC

Age Groups: adult senior

No variant requirements are available.